Publications

essay on george bush sat essay requirements no gpa no essay scholarships https://smartfin.org/science/effexor-xr-starter-pack/12/ resume interpersonal skills sample reflective narrative essay examples the facts about viagra https://www.pugetsoundnavymuseum.org/paraphrasing/russell-unpopular-essays-pdf/24/ men and women should have equal rights free essays write a thesis statement for me online follow url essay on struggle for democracy in libya https://psijax.edu/medicine/atorlip-20/50/ oque viagra an hour of story the thesis english essay of class 10 que es viagra jet go to site what time is the president's speech thesis on population geography comprare viagra cialis levitra https://academicminute.org/paraphrasing/virgin-atlantic-customers/3/ source for essay yum brands case study my biography essay examples research paper outline about global warming click essay on the lord of the flies cheap meds without a prescription write a job description for a manager essay on hard work cialis blau Center-Generated Peer-Reviewed Publications

  1. Oakley GP Jr. (2009). The Scientific Basis for Eliminating Folic Acid-Preventable Spina Bifida: A Modern Miracle from Epidemiology. Ann Epidemiol;19:226-230.
  2. Kancherla V, Chaddha M, Rowe L, Thompson A, Jain S, Walters D, Martinez H. (2021). Reducing the burden of anemia and neural tube defects in low- and middle-income countries: An analysis to identify countries with an immediate potential to benefit from large-scale mandatory fortification of wheat flour and rice. Nutrients;13(1):244. doi: 10.3390/nu13010244.
  3. Kancherla V, Koning J, Hagos M, Mersha W, Kibruyisfaw Z, Addisalem B, Koning M. (2020). Projected impact of mandatory food fortification with folic acid on nuerosurgical capacity needed for treating spina bifida in Ethiopia. Birth Defects Res. doi: 10.1002/bdr2.1857.
  4. Kancherla V, Wagh K, Pachón H, Oakley GP Jr. (2020). A 2019 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Res; 113(1):77-89
  5. Kancherla V, Tsang B, Wagh K, Dixon M, Oakley GP Jr. (2020). Modeling shows high potential of folic acid-fortified salt to accelerate global prevention of major neural tube defects. Birth Defects Res;112(18):1461-1474
  6. Kancherla V, Pachón H, Blencowe H, Martinez H, Oakley GP Jr, Berry RJ. (2020). The fallacy of using administrative data in assessing the effectiveness of food fortification. (2020). Comment on: “Folic Acid Fortification and Neural Tube Defect Risk: Analysis of the Food Fortification Initiative Dataset, Nutrients 2020, 12, 247”Nutrients;12(5):E1352
  7. Dixon M, Kancherla V, Mulugeta A, Magana T, Oakley GP Jr. (2019). High Potential for Reducing Folic Acid-Preventable Spina Bifida and Anencephaly and Related Stillbirth and Child Mortality in Ethiopia. Birth Def Res;111(19):1513-1519
  8. Kancherla V, Averbach H, Oakley GP Jr. (2019). Nation-wide failure of voluntary folic acid fortification of corn masa flour and tortillas with folic acid. Birth Defects Res;111(11):672-675
  9. Redpath B, Kancherla V, Oakley GP. Availability of corn masa flour and tortillas fortified with folic acid in Atlanta after national regulations allowing voluntary fortification. JAMA. 2018;320(15):1600-1601.
  10. Kancherla V, Wagh K, Johnson Q, Oakley GP Jr. (2018). 2017 Status of global prevention of folic acid-preventable spina bifida and anencephaly. Birth Def Res;110(14):1139-1147.
  11. Kancherla V, Redpath B, Oakley GP Jr. (2018). Reductions in child mortality by preventing spina bifida and anencephaly – Implications in achieving Target 3.2 of the Sustainable Development Goals in countries with immediate potential for folic acid fortification. Birth Defects Res  [Epub ahead of print]
  12. Kancherla V. (2018). Countries with an immediate potential for primary prevention of spina bifida and anencephaly through mandatory fortification of wheat flour with folic acid. Birth Defects Res;110(11):956-965
  13. Kancherla V, Black R. (2018). A historical perspective and challenges in estimation of global prevalence of neural tube defects. Ann NY Acad Sci;1414(1):20-30
  14. Blencowe H, Kancherla V, Moorthie S, Darlison M, Gibbons S, Modell B. (2018). Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann NY Acad Sci; 1414(1):31-46.
  15. Kancherla V, Hasan MOS, Hamid R, Oakley GP Jr., Rahman M, Quamruzzaman Q, Mazumdar M. (2017). Prenatal folic acid use associated with decreased risk of myelomeningocele: Further support for folic acid fortification in Bangladesh. PLoS One 30;12(11):e0188726
  16. Kancherla V, Oakley GP Jr. (2017). Total prevention of folic acid-preventable spina bifida and anencephaly would reduce child mortality in India – Implications in achieving Target 3.2 of the Sustainable Development Goals. Birth Defects Res;110(5):421-428
  17. Kancherla V, Weakland A, Walani S, Bauwens L, Warf B, Oakley GP Jr. (2017). Scorecard for spina bifida research, prevention, and policy – A development process. Prev Med;99:13-20.
  18. Kancherla V, Elliott JL Jr, Patel BB, Holland NW, Johnson TM 2nd, Khakharia A, Phillips LS, Oakley GP Jr., Vaughan CP. (2017). Long-term metformin therapy and monitoring for vitamin B-12 deficiency among older Veterans. J Am Geriatric Soc;65(5):1061-1066.
  19. Mukhtar A, Kramer MR, Oakley GP Jr., Kancherla V. (2017). Race and Ethnicity and preconceptional folic acid supplement use among women of reproductive age in Georgia, PRAMS 2009 to 2011. Birth Defects Res Part A Clin Mol Teratol;109(1):38-48.
  20. Kancherla V, Garn J, Zakai NA, Williamson RS, Cashion WT, Oluwaseun O, Judd S, McClellan W, Oakley GP Jr. (2016). Multivitamin use and serum vitamin B-12 levels in older-adult metformin users in REGARDS, 2003-2007. PLoS One;11(8):p.e0160802.
  21. Arth A, Kancherla V, Pachón H, Zimmerman S, Johnson Q, Oakley GP Jr. (2016). Status of global prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol;106(7):520-9.
  22. Oakley GP Jr., Kancherla V. (2016). Will the Eastern Mediterranean Region be the first to prevent all of folic acid preventable-spina bifida and anencephaly? Saudi Med J;37(1):10-11.
  23. Obeid R, Pietrzik K, Oakley GP Jr., Kancherla V, Holzgreve W, Wieser S. (2015). Preventable neural tube defects in Europe. Birth Defects Res A Clin Mol Teratol;103(9):763-71.
  24. Kancherla V, Druschel CM, Oakley GP Jr. (2014). A population-based study to investigate mortality in spina bifida – New York State Congenital Malformations Program. Birth Defects Res A Clin Mol Teratol;100(8):563-75.
  25. Kancherla V, Oakley GP Jr., Brent RL. (2013). Urgent global opportunities to prevent birth defects. Semin Fetal Neonatal Med;19(3):153-60.
  26. Youngblood M, Williamson R, Bell KN, Johnson Q, Kancherla V, Oakley GP Jr. (2013). A 2012 Update on Global Prevention of Folic Acid-Preventable Spina Bifida and Anencephaly. Birth Defects Res A Clin Mol Teratol;97(10):658-63.
  27. Pachon H, Kancherla V, Handforth B, Tyler V, Bauwens L (2013). Folic-acid fortification of wheat flour:  A cost-effective public-health intervention to prevent birth defects in Europe. Nutrition Bulletin;38:201-09.